[DNA restriction fragment length polymorphism (RFLP) of insulin and apolipoprotein A-I (apo A-I) genes in patients with diabetes mellitus coexistent with polyendocrinopathy].
作者信息
Grzywa M, Buraczyńska M, Tatoń J, Matwiszyn B
出版信息
Pol Tyg Lek. 1987 Dec 14;42(50):1598-601.
PMID:2898774
Abstract
摘要
相似文献
1
2
[Polymorphism of the apolipoprotein A-I gene and susceptibility to non-insulin-dependent diabetes mellitus].载脂蛋白A-I基因多态性与非胰岛素依赖型糖尿病易感性
Pol Tyg Lek. 1987 Dec 14;42(50):1602-5.
3
DNA polymorphisms as potential genetic risk markers for cardiovascular diseases.DNA多态性作为心血管疾病潜在的遗传风险标志物。
Boll Soc Ital Biol Sper. 1987 Sep 30;63(9):771-7.
4
Genetic polymorphisms and atherosclerosis.基因多态性与动脉粥样硬化。
Monogr Atheroscler. 1986;14:113-8.
5
6
Restriction fragment length polymorphism of the human apo B and apo AII gene regions among type II diabetics.II型糖尿病患者中人类载脂蛋白B和载脂蛋白AII基因区域的限制性片段长度多态性
Res Commun Mol Pathol Pharmacol. 1996 Jul;93(1):25-32.
7
Polymorphisms in the apolipoprotein AI-CIII gene complex.载脂蛋白AI-CIII基因复合体中的多态性。
Mol Biol Med. 1986 Jun;3(3):213-28.
8
Polymorphism of insulin gene area in Japanese: relationship with insulin-dependent and non-insulin dependent diabetes.
Biomed Biochim Acta. 1988;47(4-5):317-21.
9
Coronary artery disease, lipid disorders and genetic polymorphisms.冠状动脉疾病、脂质紊乱与基因多态性
Ann Biol Clin (Paris). 1988;46(1):24-9.
10
DNA polymorphisms flanking the apo A-1 and insulin genes and type III hyperlipidaemia.
Hum Genet. 1985;69(3):275-6. doi: 10.1007/BF00293040.
Zotero 插件